Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial

Thomas Blevins, Dominik Dahl, Federico Pérez Manghi, Sreenivasa Murthy, Ramón Ortiz Carrasquillo, Xiaoqi Li, Annette M. Chang, Molly C. Carr, Michelle L. Katz

The Lancet · 2025 · 21 citations · 13 references

Concepts

References

13